Treatment with a form of a soluble Activin receptor type IIB prevents androgen deprivation-induced changes in body composition

被引：0
|
作者：
Lachey, Jennifer [1 ]
Koncarevic, Alan [1 ]
Ucran, Jeffrey [1 ]
Pearsall, R. [1 ]
Seehra, Jasbir [1 ]
机构：
[1] Acceleron Pharma, Cambridge, MA USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2390
引用
收藏
页数：2
相关论文
共 29 条
  • [1] A Soluble Activin Receptor Type IIB Prevents the Effects of Androgen Deprivation on Body Composition and Bone Health
    Koncarevic, Alan
    Cornwall-Brady, Milton
    Pullen, Abigail
    Davies, Monique
    Sako, Dianne
    Liu, June
    Kumar, Ravindra
    Tomkinson, Kathleen
    Baker, Theresa
    Umiker, Ben
    Monnell, Travis
    Grinberg, Asya V.
    Liharska, Katia
    Underwood, Kathryn W.
    Ucran, Jeffrey A.
    Howard, Elizabeth
    Barberio, Joseph
    Spaits, Matthew
    Pearsall, Scott
    Seehra, Jasbir
    Lachey, Jennifer
    ENDOCRINOLOGY, 2010, 151 (09) : 4289 - 4300
  • [2] Effect of a soluble activin receptor type IIB on androgen-deprivation-induced effects on body composition
    Lachey, J.
    Koncarevic, A.
    Ucran, J.
    Pearsall, R. S.
    Sherman, M. L.
    Seehra, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Treatment with a soluble activin receptor type IIB attenuates glucocorticoid-induced muscle loss
    Lachey, J.
    Pullen, A.
    Pearsall, R.
    Seehra, J.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 785 - 785
  • [4] Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia
    O'Connell, Thomas M.
    Pin, Fabrizio
    Couch, Marion E.
    Bonetto, Andrea
    CANCERS, 2019, 11 (09)
  • [5] Age-Related Metabolic Dysfunction in Mice Is Attenuated by Treatment with a Form of Soluble Activin Receptor Type IIB.
    Hagerty, L.
    Lachey, J. L.
    Pearsall, R. S.
    Sherman, M.
    Seehra, J.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [6] Treatment with Soluble Activin Type IIB Receptor Ameliorates Ovariectomy-Induced Bone Loss and Fat Gain in Mice
    Puolakkainen, Tero
    Rummukainen, Petri
    Pihala-Nieminen, Vappu
    Ritvos, Olli
    Savontaus, Eriika
    Kiviranta, Riku
    CALCIFIED TISSUE INTERNATIONAL, 2022, 110 (04) : 504 - 517
  • [7] Soluble activin receptor type IIB treatment does not cause fat loss in mice with diet-induced obesity
    McPherron, A. C.
    Guo, T.
    Wang, Q.
    Portas, J.
    DIABETES OBESITY & METABOLISM, 2012, 14 (03): : 279 - 282
  • [8] Treatment with Soluble Activin Type IIB Receptor Ameliorates Ovariectomy-Induced Bone Loss and Fat Gain in Mice
    Tero Puolakkainen
    Petri Rummukainen
    Vappu Pihala-Nieminen
    Olli Ritvos
    Eriika Savontaus
    Riku Kiviranta
    Calcified Tissue International, 2022, 110 : 504 - 517
  • [9] A Soluble Activin Type IIB Receptor Facilitates Muscle Recovery from Cardiotoxin-induced Injury
    Koncarevic, Alan
    Cadena, Samuel
    Mitchell, Dianne
    Lachey, Jennifer
    Seehra, Jasbir
    NEUROLOGY, 2009, 72 (11) : A20 - A20
  • [10] Treatment with a soluble Activin type IIB receptor increases muscle size and strength of dystrophin deficient muscle
    Lachey, J. L.
    Pistilli, E. E.
    Bogdanovich, S.
    Pullen, A. E.
    Pearsall, R. S.
    Khurana, T. S.
    Seehra, J.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 783 - 783
123